126 related articles for article (PubMed ID: 3984660)
1. Enhanced hypothalamic dopaminergic inhibition of LH, TSH and GH release in patients with pathological hyperprolactinaemia.
Ho KY; Smythe GA; Lazarus L
Acta Endocrinol (Copenh); 1985 Mar; 108(3):289-96. PubMed ID: 3984660
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic control of gonadotrophin secretion in normal women and in patients with pathological hyperprolactinaemia.
Ho KY; Smythe GA; Lazarus L
Clin Endocrinol (Oxf); 1984 Jan; 20(1):53-63. PubMed ID: 6420095
[TBL] [Abstract][Full Text] [Related]
3. Evidence of altered dopaminergic modulation of Prl, LH, FSH, GH and TSH secretion during chronic partial dopamine receptor blockade in normal women.
Hagen C; Andersen AN; Djursing H
Acta Endocrinol (Copenh); 1984 May; 106(1):1-7. PubMed ID: 6428112
[TBL] [Abstract][Full Text] [Related]
4. The effect of contraceptive steroids on hypothalamic-pituitary function.
Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
[TBL] [Abstract][Full Text] [Related]
5. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
González LC; Pinilla L; Tena-Sempere M; Aguilar E
J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
[TBL] [Abstract][Full Text] [Related]
6. Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.
Ghigo E; Ciccarelli E; Novelli A; Massobrio M; Müller EE; Camanni F
J Endocrinol Invest; 1985 Feb; 8(1):35-40. PubMed ID: 3989236
[TBL] [Abstract][Full Text] [Related]
7. Evidence of altered dopaminergic modulation of Prl, LH and TSH secretion in patients with normoprolactinaemic amenorrhoea.
Hagen C; Petersen K; Djursing H; Andersen AN
Acta Endocrinol (Copenh); 1984 May; 106(1):8-14. PubMed ID: 6428118
[TBL] [Abstract][Full Text] [Related]
8. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
Scanlon MF; Rodriguez-Arnao MD; McGregor AM; Weightman D; Lewis M; Cook DB; Gomez-Pan A; Hall R
Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201
[TBL] [Abstract][Full Text] [Related]
9. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
[TBL] [Abstract][Full Text] [Related]
10. Dopamine affects basal and augmented pituitary hormone secretion.
Leebaw WF; Lee LA; Woolf PD
J Clin Endocrinol Metab; 1978 Sep; 47(3):480-7. PubMed ID: 122408
[TBL] [Abstract][Full Text] [Related]
11. Possible altered dopaminergic modulation of pituitary function in normal-menstruating women with insulin dependent diabetes mellitus (IDDM).
Djursing H; Carstensen L; Hagen C; Andersen AN
Acta Endocrinol (Copenh); 1984 Dec; 107(4):450-5. PubMed ID: 6440390
[TBL] [Abstract][Full Text] [Related]
12. Prolactin levels and the response to central dopamine synthesis blockade in subjects on oral contraceptives.
Smythe GA; Ho K; Lazarus L
IRCS J Med Sci; 1982 Feb; 10(2):124. PubMed ID: 12279213
[TBL] [Abstract][Full Text] [Related]
13. Prl, TSH, GH and LH responses to metoclopramide and breast-feeding in normal and hyperprolactinaemic women.
Andersen AN; Tabor A
Acta Endocrinol (Copenh); 1982 Jun; 100(2):177-83. PubMed ID: 7202316
[TBL] [Abstract][Full Text] [Related]
14. Reduced dopaminergic inhibition of thyrotrophin release in states of physiological hyperprolactinaemia.
Rodriguez-Arnao MD; Weightman DR; Hall R; Scanlon MF; Camporro JM; Gomez-Pan A
Clin Endocrinol (Oxf); 1982 Jul; 17(1):15-9. PubMed ID: 7116653
[TBL] [Abstract][Full Text] [Related]
15. The influence of oestrogens on the sensitivity of PRL, TSH and LH to the inhibitory actions of dopamine in hyperprolactinaemic patients.
Valcavi R; Harris PE; Foord SM; Dieguez C; Evans PJ; Peters JR; Hall R; Scanlon MF
Clin Endocrinol (Oxf); 1985 Aug; 23(2):139-46. PubMed ID: 4053412
[TBL] [Abstract][Full Text] [Related]
16. Prolactin and TSH responses to both domperidone and TRH in normal and hyperprolactinaemic women after dopamine synthesis blockade.
Ghigo E; Goffi S; Molinatti GM; Camanni F; Massara F
Clin Endocrinol (Oxf); 1985 Aug; 23(2):155-60. PubMed ID: 3931942
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia.
Massara F; Camanni F; Martra M; Dolfin GC; Müller EE; Molinatti GM
Clin Endocrinol (Oxf); 1983 Feb; 18(2):103-10. PubMed ID: 6851194
[TBL] [Abstract][Full Text] [Related]
18. Interaction of dopaminergic and antiserotoninergic drugs in the control of prolactin and LH release in normal women.
Pontiroli AE; Alberetto M; Pellicciotta G; De Castro e Silva E; De Pasqua A; Girardi AM; Pozza G
Acta Endocrinol (Copenh); 1980 Mar; 93(3):271-6. PubMed ID: 7376792
[TBL] [Abstract][Full Text] [Related]
19. Some aspects of hypothalamic-pituitary function in patients with anorexia nervosa.
Travaglini P; Beck-Peccoz P; Ferrari C; Ambrosi B; Paracchi A; Severgnini A; Spada A; Faglia G
Acta Endocrinol (Copenh); 1976 Feb; 81(2):252-62. PubMed ID: 813472
[TBL] [Abstract][Full Text] [Related]
20. Evidence of altered dopaminergic modulation of prolactin and thyrotropin secretion in patients with polycystic ovary syndrome.
Velardo A; Pantaleoni M; Zironi C; Zizzo G; Marrama P
Horm Res; 1991; 35(1):4-7. PubMed ID: 1916652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
